Peaks of Interest
PerkinElmer sells aerospace business to focus on health sciences
PerkinElmer, Inc. (Shelton, Connecticut) recently announced that it plans to divest the fluid sciences business segment to increase the company's strategic focus on its health sciences and photonic markets. The company has signed an agreement to sell its aerospace business to Eaton Corporation for $333 million.
The company also reported that it is in discussions to sell its semiconductor and fluid testing businesses. All planned divestitures are expected to be completed by 2006 with aggregate proceeds of $400 million from the sale of the Fluid Sciences business segment.
Lab Spray Dryers
Shimadzu's LC–MS-IT-TOF mass spectrometer wins R&D 100 Award
Shimadzu Scientific Instruments, Inc. (Columbia, Maryland) recently announced that its hybrid Ion Trap-Time-of-Flight mass spectrometer has received the R&D 100 award from R&D Magazine.
Shimadzu's LCMS-IT-TOF is designed for a wide range of uses including biomarker studies, metabolomics, proteomics, metabolite identification, environmental analyses, forensics use, and homeland security functions.
Applied Biosystems sells to Centers for Disease Control and Prevention
Applied Biosystems Group (Foster City, California) and MDS Sciex (Concord, Ontario, Canada) recently announced the sale of 21 API 4000 LC–MS-MS systems to the Centers for Disease Control and Prevention (CDC) and several state health laboratories. These systems will be part of the Laboratory Response Network, providing a validated platform for identifying harmful chemical agents nationwide.
Utilizing the LC–MS-MS system with validated assays, laboratory personnel can screen for and identify chemicals in human blood or urine samples, including mustard agents, nerve agents, and other toxic chemicals.
Novasep Process nominated to 2005 CPhI Innovation Awards
Novasep Process recently has been selected to participate to the 2005 CPhI innovation awards selection and will present a conference entitled "Latest Advances in Preparative Supercritical Fluid Chromatographic Separation Technologies" in Madrid in November.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
